Fluticasone/Salmeterol
Showing 1 - 25 of 702
A Retrospective rEal-life daTa Study to Assess exaceRbations and
Completed
- COPD
- COPD Exacerbation
-
Thessaloniki, GreecePapanikolaou Hospital of Thessaloniki
Sep 7, 2022
Asthma Trial (RP - TA)
Completed
- Asthma
- RP - TA
- (no location specified)
Jul 12, 2022
Bioequivalence Trial in Larissa (Fluticasone propionate 500 mcg and salmeterol xinafoate 50 mcg/Respirent Pharmaceuticals,
Recruiting
- Bioequivalence
- Fluticasone propionate 500 mcg and salmeterol xinafoate 50 mcg/Respirent Pharmaceuticals
- ADVAIR DISKUS® 500/50
-
Larissa, Thessaly, GreeceBECRO Clinical Facility
Aug 29, 2023
Asthma Trial (mometasone furoate combination MDI 200/10 mcg BID, mometasone furoate combination MDI 400/10 mcg BID,
Completed
- Asthma
- mometasone furoate combination MDI 200/10 mcg BID
- +3 more
- (no location specified)
Feb 7, 2022
Bioequivalence Trial in Larissa (Fluticasone propionate 250 mcg and salmeterol xinafoate 50 mcg/Respirent Pharmaceuticals,
Recruiting
- Bioequivalence
- Fluticasone propionate 250 mcg and salmeterol xinafoate 50 mcg/Respirent Pharmaceuticals
- ADVAIR DISKUS® 250/50
-
Larissa, Thessaly, GreeceBECRO Clinical Facility
Aug 1, 2023
Altitude Edema Trial (Advair HFA, Placebo)
Not yet recruiting
- Altitude Edema
- Advair HFA
- Placebo
- (no location specified)
Sep 8, 2023
Bioequivalence Trial (Fluticasone propionate 1000 mcg and salmeterol xinafoate 50 mcg/Respirent Pharmaceuticals, ADVAIR DISKUS
Not yet recruiting
- Bioequivalence
- Fluticasone propionate 1000 mcg and salmeterol xinafoate 50 mcg/Respirent Pharmaceuticals
- ADVAIR DISKUS 100/50
- (no location specified)
Jan 20, 2023
Asthma Trial in Athens (Fluticasone Propionate 100 mcg and Salmeterol 50 mcg inhalation Powder/Respirent Pharmaceuticals, ADVAIR
Not yet recruiting
- Asthma
- Fluticasone Propionate 100 mcg and Salmeterol 50 mcg inhalation Powder/Respirent Pharmaceuticals
- +2 more
-
Athens, GreeceBECRO Ltd.
Jan 20, 2023
COPD Trial in Antalya (Salmeterol/Fluticasone Capsair®, Salmeterol/Fluticasone Diskus®)
Terminated
- COPD
- Salmeterol/Fluticasone Capsair®
- Salmeterol/Fluticasone Diskus®
-
Antalya, Turkey
- +1 more
May 16, 2022
Asthma Trial in Hackensack, New York (Fluticasone with salmeterol, Fluticasone HFA)
Completed
- Asthma
- Fluticasone with salmeterol
- +3 more
-
Hackensack, New Jersey
- +2 more
Oct 12, 2022
Asthma Trial in Huntington Beach, Raleigh, San Antonio (Fluticasone Propionate MDPI, Fluticasone Propionate/Salmeterol MDPI,
Completed
- Asthma
- Fluticasone Propionate MDPI
- +2 more
-
Huntington Beach, California
- +2 more
Nov 5, 2021
Asthma Trial in Miami Lakes (Fluticasone Propionate and Salmeterol Inhalation Powder, Placebo Inhalation Powder)
Completed
- Asthma
- Fluticasone Propionate and Salmeterol Inhalation Powder
- Placebo Inhalation Powder
-
Miami Lakes, FloridaStudy Site 101
Aug 31, 2021
Asthma Trial in Raleigh, Edmond, San Antonio (Treatment A: Fp MDPI, Treatment B: FS MDPI, Treatment C Flovent)
Completed
- Asthma
- Treatment A: Fp MDPI
- +3 more
-
Raleigh, North Carolina
- +2 more
Nov 6, 2021
Asthma Trial in Czechia (Elpenhaler active - Diskus )
Completed
- Asthma
- Elpenhaler active - Diskus placebo
-
Karlovy Vary, Drahovice, Czechia
- +4 more
Apr 8, 2021
Asthma Trial (Mometasone furoate/formoterol (MF/F) MDI, Fluticasone propionate/salmeterol (F/SC) DPI)
Completed
- Asthma
- Mometasone furoate/formoterol (MF/F) MDI
- Fluticasone propionate/salmeterol (F/SC) DPI
- (no location specified)
Feb 7, 2022
Copd Trial in Assiut (SABA SAMA ICS Vs LABA LAMA ICs)
Not yet recruiting
- Copd
- SABA SAMA ICS Vs LABA LAMA ICs
-
Assiut, EgyptNermen Mohammed Abuelkassem
Feb 28, 2023
Asthma in Children Trial in Cincinnati (Cholecalciferol, antihistamine, Azithromycin)
Completed
- Asthma in Children
- Cholecalciferol
- +5 more
-
Cincinnati, OhioCincinnati Children's Hospital Medical Center
Jul 28, 2021
Asthma, COPD Trial in San Antonio (MGR001, Advair® Diskus®, Seretide™ Accuhaler™)
Completed
- Asthma
- COPD
- MGR001
- +2 more
-
San Antonio, TexasWorldwide Clinical Trials Early Phase Services
Feb 22, 2022
Replication of the INSPIRE Trial in Healthcare Claims Data
Completed
- Chronic Obstructive Pulmonary Disease
-
Boston, MassachusettsBrigham and Women's Hospital
Dec 16, 2021
Bioequivalence Trial in Larissa (Fluticasone propionate 500 mcg and salmeterol xinafoate 50 mcg/Respirent, ADVAIR DISKUS®
Completed
- Bioequivalence
- Fluticasone propionate 500 mcg and salmeterol xinafoate 50 mcg/Respirent
- ADVAIR DISKUS® 500/50
-
Larissa, Thessaly, GreeceBECRO Clinical Facility
Mar 8, 2021
Bioequivalence Trial in Larissa (Test Product, Reference Product)
Completed
- Bioequivalence
- Test Product
- Reference Product
-
Larissa, Thessaly, GreeceBECRO Clinical Facility
Mar 8, 2021